All five of the identified genes (DLK1, PLAGL1, SLC22A18, TP73, and WT1) have presumed tumor suppressing functions and taken together demonstrate a strong tendency towards higher methylation at the CpG sites assessed. The gene discussed is TP73; the disease is neoplasm.